當升科技(300073.SZ):擬投資擴建江蘇當升鋰電正極材料生產基地前驅體產線項目
格隆匯9月16日丨當升科技(300073.SZ)公佈,公司於2022年9月16日召開了第五屆董事會第十四次會議,會議以9票同意、0票反對、0票棄權的表決結果審議通過了《關於江蘇當升鋰電正極材料生產基地前驅體擴建產線項目的議案》,決定由公司子公司江蘇當升材料科技有限公司(以下稱“江蘇當升”)使用自籌資金及銀行貸款投資擴建江蘇當升鋰電正極材料生產基地前驅體產線(以下稱“前驅體擴建項目”)。
前驅體擴建項目總投資額人民幣1.5932億元,將建成年產10000噸前驅體產能及配套輔助設施。此次擴建產能完成後,公司前驅體產能將達到15000噸/年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.